Seven Mile Advisory »

Allogene Therapeutics shares owned by Seven Mile Advisory

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Seven Mile Advisory from 13F filings

Historical chart of Seven Mile Advisory investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Seven Mile Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Seven Mile Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 14k 1.24
2025-06-30 $16k 14k 1.13
2025-03-31 $15k 11k 1.46

More positions owned by Seven Mile Advisory

Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mortgage-backed Securities Etf Etf (VMBS)
Ishares S&p 100 Etf Etf (OEF)
Nvidia Corporation Stock (NVDA)
Vanguard Total Stock Market Etf Etf (VTI)
Dimensional International Value Etf Etf (DFIV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Value ETF Etf (VTV)
Vanguard Short-term Treasury Etf Etf (VGSH)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Vanguard Intermediate-term Treasury Etf Etf (VGIT)
Microsoft Corp Stock (MSFT)

View all positions for Seven Mile Advisory

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics